16088232

Source:http://linkedlifedata.com/resource/pubmed/id/16088232

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0069717, umls-concept:C0205179, umls-concept:C0444889, umls-concept:C0671970, umls-concept:C1516213, umls-concept:C1527249
pubmed:issue	1
pubmed:dateCreated	2005-8-24
pubmed:abstractText	The aim of the study was to define the feasibility and efficacy of Xelox (capecitabine and oxaliplatin) administered through a new and original schedule in advanced pretreated colorectal cancer (CRC) patients.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0135054
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Camptothecin, http://linkedlifedata.com/resource/pubmed/chemical/Deoxycytidine, http://linkedlifedata.com/resource/pubmed/chemical/Fluorouracil, http://linkedlifedata.com/resource/pubmed/chemical/Organoplatinum Compounds, http://linkedlifedata.com/resource/pubmed/chemical/capecitabine, http://linkedlifedata.com/resource/pubmed/chemical/irinotecan, http://linkedlifedata.com/resource/pubmed/chemical/oxaliplatin
pubmed:status	MEDLINE
pubmed:issn	0030-2414
pubmed:author	pubmed-author:CaricatoMarcoM, pubmed-author:CoppolaRobertoR, pubmed-author:Di SeriMarisaM, pubmed-author:La CesaAnnalisaA, pubmed-author:RocciLauraL, pubmed-author:SantiniDanieleD, pubmed-author:SchiavonGaiaG, pubmed-author:SpallettaBrunoB, pubmed-author:ToniniGiuseppeG, pubmed-author:VincenziBrunoB
pubmed:issnType	Print
pubmed:volume	69
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	27-34
pubmed:dateRevised	2006-4-24
pubmed:meshHeading	pubmed-meshheading:16088232-Adult, pubmed-meshheading:16088232-Aged, pubmed-meshheading:16088232-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:16088232-Camptothecin, pubmed-meshheading:16088232-Chronotherapy, pubmed-meshheading:16088232-Colorectal Neoplasms, pubmed-meshheading:16088232-Deoxycytidine, pubmed-meshheading:16088232-Disease Progression, pubmed-meshheading:16088232-Drug Administration Schedule, pubmed-meshheading:16088232-Drug Resistance, Neoplasm, pubmed-meshheading:16088232-Female, pubmed-meshheading:16088232-Fluorouracil, pubmed-meshheading:16088232-Humans, pubmed-meshheading:16088232-Infusions, Intravenous, pubmed-meshheading:16088232-Male, pubmed-meshheading:16088232-Middle Aged, pubmed-meshheading:16088232-Neoplasm Staging, pubmed-meshheading:16088232-Organoplatinum Compounds, pubmed-meshheading:16088232-Survival Analysis, pubmed-meshheading:16088232-Treatment Outcome
pubmed:year	2005
pubmed:articleTitle	Continuous infusion of oxaliplatin plus chronomodulated capecitabine in 5-fluorouracil- and irinotecan-resistant advanced colorectal cancer patients.
pubmed:affiliation	Medical Oncology, University Campus Bio-Medico, Rome, Italy. d.santini@unicampus.it
pubmed:publicationType	Journal Article